Carmichael Hill & Associates’s Royce Value Trust RVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$13.3K Hold
850
﹤0.01% 553
2024
Q2
$12.3K Hold
850
﹤0.01% 548
2024
Q1
$12.9K Hold
850
0.01% 540
2023
Q4
$12.4K Sell
850
-561
-40% -$7.32K 0.01% 550
2023
Q3
$18.2K Hold
1,411
0.01% 484
2023
Q2
$19.5K Hold
1,411
0.01% 473
2023
Q1
$19.1K Hold
1,411
0.01% 460
2022
Q4
$18.7K Hold
1,411
0.01% 476
2022
Q3
$18K Hold
1,411
0.01% 498
2022
Q2
$20K Hold
1,411
0.01% 473
2022
Q1
$24K Sell
1,411
-289
-17% -$5.06K 0.01% 474
2021
Q4
$33K Hold
1,700
0.01% 438
2021
Q3
$31K Hold
1,700
0.02% 451
2021
Q2
$32K Hold
1,700
0.02% 445
2021
Q1
$31K Hold
1,700
0.02% 426
2020
Q4
$27K Hold
1,700
0.02% 425
2020
Q3
$21K Hold
1,700
0.01% 424
2020
Q2
$21K Hold
1,700
0.02% 406
2020
Q1
$16K Hold
1,700
0.01% 399
2019
Q4
$25K Buy
+1,700
New +$24.1K 0.02% 367

Other funds holding RVT

Carmichael Hill & Associates's RVT Position: Q3 2024 in Review

Carmichael Hill & Associates held its Royce Value Trust (RVT) position steady in Q3 2024 at 850 shares worth $13.3K. The position accounts for ﹤0.01% of the portfolio, ranked #553.

Carmichael Hill & Associates first reported a position in RVT in Q4 2019 and has held it in 20 quarters since. The position peaked at $33K in Q4 2021. 184 funds tracked by Wall St. Rank hold RVT as of Q3 2024.

  • Carmichael Hill & Associates held 850 shares of Royce Value Trust worth $13.3K as of Q3 2024.
  • Carmichael Hill & Associates left its Royce Value Trust share count unchanged in Q3 2024.
  • Royce Value Trust made up ﹤0.01% of Carmichael Hill & Associates's portfolio in Q3 2024, its #553 holding.
  • Carmichael Hill & Associates first reported a position in Royce Value Trust in Q4 2019 and has held it in 20 quarters since.
  • Carmichael Hill & Associates's Royce Value Trust position peaked at $33K in Q4 2021.
  • 184 funds tracked by Wall St. Rank held Royce Value Trust as of Q3 2024.

Based on Carmichael Hill & Associates's 13F filing for Q3 2024, filed 29 Oct 2024.